Member Info for ak_gabba

Wilson63,

I don't see NCYT , microgen or primerdesign being part of the link you posted - http://bidstats.uk/tenders/2021/W16/749469707

Have I missed something?

There was minus £181.8m recorded against Innova for April 21 in the dhsc spend over £25k report.
I've not found anything to explain that.

innova is listed under supplier PGO foreign currency payments however they are listed as innova medical under PO line description.
£1.8bn in total

MS,
Yes it looks that way. The below link is from 26th Nov 2020 which is based on their statement from 24th Nov 2020. I imagine it took days if not weeks to run through their in-house testing prior to releasing the statement.

https://www.ibms.org/resources/news/sars-cov-2-rapid-testing-options/

PROmate was reported to be launched on 16th Nov 2020 through an R&D RNS

https://www.lse.co.uk/rns/NCYT/rd-update-z33m1gapau1iph7.html

I'm guessing the statement didn't have PROmate to work with at that point. Can't find anything on IBMS in relation to PROmate but i'll keep digging.

March and April data for this year was released end of May. Downloaded the data and updated my pivots.

I've grabbed some companies that I keep an eye on. There might be a few I haven't picked up on.

Here is a link to a screenshot of some of the data. Link is also there for original source.

https://twitter.com/ak_gabba/status/1400073816261472260

https://financialpost.com/pmn/business-pmn/abbott-cuts-2021-profit-forecast-on-lower-covid-19-testing-demand-2

"The new guidance from the Centers for Disease Control and Prevention issued in May allows people who have been vaccinated to travel in the U.S. without getting tested before or after travel"

"The company forecast 2021 sales related to COVID-19 testing between $4.0 billion and $4.5 billion, compared with its prior outlook of $6.5 billion to $7.0 billion"

Thanks to MartinMatinTH on twitter for this find

https://twitter.com/MartinMatinTH/status/1398221870030372868

poidster post is still available to view if you search the username however the thread is gone so the discussion can't be viewed.

its very similar opinion to mine which I and others have shared however poidster can get closer to the source than I can.

Hopefully a successful resolution can be agreed which allows both parties to continue their business together.

Part 2

9th April 2021 Trading Update

https://www.lse.co.uk/rns/NCYT/trading-update-74tpjo9hz25buh8.html

“Unfortunately, an extension has not been agreed, although the Company supplied PROmate™ in Q1 2021 in accordance with DHSC demand”

Note the word demand.

Link to screenshot of pivot table of the available DHSC spend over £25k which others have also worked ??

https://twitter.com/ak_gabba/status/1390387638960537604

It is my interpretation that there have been usage issues with the pre PROmate tests and this could well be what the dispute is about as some others have also alluded. I am unsure of the current status of the Q16/Q32 machines. How many were rolled out? How many are still in use?

This freedom of information request has still to be responded to

https://www.whatdotheyknow.com/request/primerdesign_pcr_tests_and_q16_q

Perhaps due to the dispute?

Part 1

Some healthy and constructive discussions going on. Below is a summary of PROmate which may be helpful to some but may already be known to others.

Launch of PROmate announced 16th Nov 2020

https://www.lse.co.uk/rns/NCYT/rd-update-z33m1gapau1iph7.html

“Launch of PROmate™
PROmate™ is a new CE Mark approved product designed to further improve the workflow efficiency of COVID-19 testing when used in combination with the Company's q16 and q32 instruments. The reagents involved in the Company's COVID-19 RNA extraction and PCR test products have been repackaged, with some reagents also freeze-dried, to reduce the amount of consumables and the number of steps required, thereby reducing operator complexity and improving cycle times. In addition, PROmate™ uses a viral inactivation methodology validated by Public Health England for potential use outside of laboratory environments.”
I have spotted tweets after this date from lab staff who were having issues. This would have been before the TVG report and may well have required the TVG to be involved.

29th Jan Trading Update

https://www.lse.co.uk/rns/NCYT/full-year-2020-trading-update-6ysk8nfjt25lfvw.html

“In addition, the Company continues to support the DHSC and the NHS following the deployment of its rapid PCR testing system, for the contract with the DHSC, announced on 29 September 2020, and the Company is in active discussions with the DHSC to extend this phase of the contract. Novacyt's PROmate™, a new product to improve the workflow efficiency when used with the Company's q16/q32 instruments successfully completed an in-service validation conducted by Test and Trace's Technology Validation Group (TVG), with the TVG concluding the performance of the PROmate™ aligns with the acceptable standard for point-of-care (rapid testing).”

Feb 2021 TVG report

https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/957995/TVG_Report-PROmate.pdf

4th Feb 2021 government briefing (updates listed as 3rd Feb 6.43pm)

https://www.stcuthbertout-pc.gov.uk/uploads/govuk-daily-briefing-4th-february-2021.pdf

Note the summary of one of the updates.

“Assessment and procurement of coronavirus (COVID-19) tests
Page summary: How the government assesses offers of COVID-19 tests from developers for procurement and use in the UK.”

The TVG report has a publish date of February 2021 however it was referenced in an RNS on 29th Jan.

24th Feb 2021 R&D update

https://www.lse.co.uk/rns/NCYT/research-and-development-update-7iu0u64rk16dtin.html

“Of note, following its launch, our PROmate™ test has been well received by users and opens up new opportunities for rapid PCR testing, including in private testing markets”

The above statement is very encouraging considering the tweets from November.

It's a quote from Alex Welte but it's clearly been chosen from whoever runs the social media marketing department. Cryptic!
One thing is for sure they are trying to align themselves with respected scientists within this field and showing it through their webinars. It's nice to see but would prefer more positive contract news

troublesome,

The last line in the article is

"Management was quick to react when Covid struck, unfortunately they appear to be less well equipped to deal with the current dispute"

They are indicating how fast novacyt were to react to covid while suggesting they haven't been as quick and/or as efficient to react to the dispute.

I guess what they are really saying is great at the science, not so good at the contracts.

was hoping for a successful resolution instead we get may have material impact on Q1 2021 revenues as well as Q4 2020.

it would appear the whole second contract is under dispute.

https://www.standard.co.uk/business/pharmaceuticals/covid19-test-novacyt-dcms-contract-b936528.html

Porky9,

8m+ short? thats over 10% of the shares being shorted. I thought the short was around 1%

with music from Leftfield "Phat Planet" (pre release)
1998? Has it really been that long?

Kaeren,

thanks for the link - this one https://twitter.com/IndependentSage/status/1393182569420627972?s=20

very informative. only half way in but i'll be re-watching this over the weekend

it reminded me of this test

https://www.ft.com/content/e7a279df-3239-4e00-be29-f38d98f4d730

https://www.pelicandetect.com/newsroom/pelican-25-second-98-sensitivity-digital-covid-19-saliva-test-achieves-ce-mark

seems to have went under the radar. myself included

link from within Larry's tweet

https://www.medrxiv.org/content/10.1101/2021.05.07.21256745v1

"To assess the efficacy of rapid direct-to-PCR assays and systems for the detection of SARS-CoV-2 in the hospital, care home and medical research population in England from November 2020 to April 2021"

"These results show that direct-to-PCR assay perform equivalently to the gold standard centralised laboratory RT-PCR systems for the detection of SARS-CoV-2"

Excellent find Larry!

Larry10,
The link you posted on twitter (thanks!) has a graph comparing H1 2019 and H1 2020. It has americas down as 1.3m for H1 2019 and 3.8m for H1 2020.
I'm not sure where they got their breakdown from but it doesn't link in with doing the best sells. Unless of course H2 2020 blows it out of the park.

Here are the links for others (i think it's already been posted on this board)
https://twitter.com/Larry64450205/status/1392517948070301697
https://www.cafedelabourse.com/actualites/novacyt-action-en-bourse